» Articles » PMID: 8370570

Dopamine Formation, from Its Immediate Precursor 3,4-dihydroxyphenylalanine, Along the Rat Digestive Tract

Overview
Specialty Pharmacology
Date 1993 Jan 1
PMID 8370570
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

The formation of dopamine, from L-3,4-dihydroxyphenylalanine (L-dopa), in fragments of non-glandular and glandular stomach, duodenum, jejunum, ileum and proximal and distal colon of the rat was examined. The deamination of newly-formed dopamine into 3,4-dihydroxyphenylacetic acid (dopac) was also studied. The synthesis of dopamine in tissues incubated with 500 microM L-dopa for 20 min in conditions of catechol-O-methyltransferase (Comt) inhibition was found to be in the duodenum, jejunum and ileum 2-fold that in the proximal colon, 6-fold that in the glandular stomach and 120-fold that in the non-glandular stomach and distal colon. The formation of dopac in these tissues followed the pattern of amine formation. In the jejunum, the formation of dopamine and dopac was found to be dependent on the concentration of L-dopa (50 to 5000 microM) used. In another set of experiments, it was found that the formation of dopamine in jejunal segments loaded with increasing concentrations of L-dopa (50, 100 and 500 microM) was a time-dependent process. The rate constant (k) of formation of dopamine as a function of time was found to be similar (0.050 +/- 0.005) with either concentration of L-dopa; the rate constant of dopac formation in these experiments was, in contrast, found to be greater at the highest concentrations of L-dopa (100 and 500 microM). Aromatic L-amino acid decarboxylase (Aaad) activity determined in homogenates of the jejunal mucosa was found to be twice that observed in homogenates of the remaining jejunal wall (muscular).(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

Growing meat on autoclaved vegetables with biomimetic stiffness and micro-patterns.

Liu Y, Gao A, Wang T, Zhang Y, Zhu G, Ling S Nat Commun. 2025; 16(1):161.

PMID: 39746945 PMC: 11695936. DOI: 10.1038/s41467-024-55048-6.


Research progress on the roles of dopamine and dopamine receptors in digestive system diseases.

Lu X, Liu Q, Deng Y, Wu J, Mu X, Yang X J Cell Mol Med. 2024; 28(7):e18154.

PMID: 38494840 PMC: 10945074. DOI: 10.1111/jcmm.18154.


Evidence for dopamine production and distribution of dopamine D2 receptors in the equine gastrointestinal mucosa and pancreas.

Galinelli N, Bamford N, de Laat M, Sillence M, Harris P, Bailey S PLoS One. 2024; 19(2):e0298660.

PMID: 38412155 PMC: 10898723. DOI: 10.1371/journal.pone.0298660.


Anti-Inflammatory Effects of Peripheral Dopamine.

Moore S, de Castro P, Yaqub D, Jose P, Armando I Int J Mol Sci. 2023; 24(18).

PMID: 37762126 PMC: 10530375. DOI: 10.3390/ijms241813816.


D-DOPA Is a Potent, Orally Bioavailable, Allosteric Inhibitor of Glutamate Carboxypeptidase II.

Gori S, Thomas A, Pal A, Wiseman R, Ferraris D, Gao R Pharmaceutics. 2022; 14(10).

PMID: 36297453 PMC: 9608075. DOI: 10.3390/pharmaceutics14102018.